Reply

Ikuo Hirano; Margaret H. Collins; David A. Katzka; Vincent A. Mukkada; Gary W. Falk; Robin Morey; Nirav K. Desai; Lan Lan; James Williams; Evan S. Dellon

doi:10.1016/j.cgh.2021.06.033

Reply

Ikuo Hirano, Margaret H. Collins, David A. Katzka, Vincent A. Mukkada, Gary W. Falk, Robin Morey, Nirav K. Desai, Lan Lan, James Williams, Evan S. Dellon

Medicine, Gastroenterology Division

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1189-1190
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	20
Issue number	5
DOIs	https://doi.org/10.1016/j.cgh.2021.06.033
State	Published - May 2022

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1016/j.cgh.2021.06.033

Cite this

@article{9930ece57de34c4aa5569158af4c67c0,

title = "Reply",

author = "Ikuo Hirano and Collins, {Margaret H.} and Katzka, {David A.} and Mukkada, {Vincent A.} and Falk, {Gary W.} and Robin Morey and Desai, {Nirav K.} and Lan Lan and James Williams and Dellon, {Evan S.}",

note = "Funding Information: Medical writing support was provided by Luci Witcomb, PhD, of PharmaGenesis London and was funded by Takeda Pharmaceuticals USA, Inc. Funding Information: Funding This study was funded by Shire ViroPharma, Inc , a member of the Takeda group of companies. ",

year = "2022",

month = may,

doi = "10.1016/j.cgh.2021.06.033",

language = "English (US)",

volume = "20",

pages = "1189--1190",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - Reply

AU - Hirano, Ikuo

AU - Collins, Margaret H.

AU - Katzka, David A.

AU - Mukkada, Vincent A.

AU - Falk, Gary W.

AU - Morey, Robin

AU - Desai, Nirav K.

AU - Lan, Lan

AU - Williams, James

AU - Dellon, Evan S.

N1 - Funding Information: Medical writing support was provided by Luci Witcomb, PhD, of PharmaGenesis London and was funded by Takeda Pharmaceuticals USA, Inc. Funding Information: Funding This study was funded by Shire ViroPharma, Inc , a member of the Takeda group of companies.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85111506001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111506001&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2021.06.033

DO - 10.1016/j.cgh.2021.06.033

M3 - Letter

C2 - 34214677

AN - SCOPUS:85111506001

SN - 1542-3565

VL - 20

SP - 1189

EP - 1190

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 5

ER -

Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this